Bio-Rad Laboratories, Inc. BIO | NYSE

$327.47 $1.53 | 0.47%

After Hours
$392 $64.53 | 19.71%

Company Overview:

Market Cap: $9.18B
PE Ratio: -11.65
52-Week Range: $262.12 - $387.99
Dividend Yield (FWD): 0.00% ($0.00)

10 Year Performance Metrics:

Total Return (with DRIP): 170.55% (10.46% / yr)
Total Return (no DRIP): 170.55% (10.46% / yr)
Share Price: 170.55%
Dividend Increase: nan%
BIO 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

BIO Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
BIO Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
BIO Price CAGR:1Y: 6.21%2Y: -9.61%5Y: -2.56%10Y: 10.44%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

BIO Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - BIO
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - BIO
14-Day FREE Trial Get Full Access Now!

BIO Earnings, Revenue, Cash & Debt, Shares Outstaning:

BIO - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
BIO - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
BIO - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
BIO - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
BIO - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
BIO - Cash & Debt
14-Day FREE Trial Get Full Access Now!
BIO - Revenue
14-Day FREE Trial Get Full Access Now!
BIO Revenue CAGR:1Y: 2.79%2Y: -2.31%5Y: 2.99%10Y: 2.05%
BIO - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
BIO EPS CAGR:1Y: 541.21%2Y: 149.56%5Y: 36.21%10Y: 50.56%
BIO - Net Income
14-Day FREE Trial Get Full Access Now!
BIO Net Income CAGR:1Y: 514.71%2Y: 144.48%5Y: 35.24%10Y: 49.76%
BIO - EBITDA
14-Day FREE Trial Get Full Access Now!
BIO EBITDA CAGR:1Y: 520.56%2Y: 167.91%5Y: 53.93%10Y: 29.24%
BIO - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
BIO Free Cash Flow CAGR:1Y: 86.37%2Y: 183.57%5Y: 7.80%10Y: 4.69%
BIO - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
BIO Free Cash Flow / Share CAGR:1Y: 94.06%2Y: 190.20%5Y: 9.21%10Y: 5.04%
BIO - Gross Profit
14-Day FREE Trial Get Full Access Now!
BIO Gross Profit CAGR:1Y: 6.02%2Y: -2.42%5Y: 3.00%10Y: 2.12%
BIO - Expenses
14-Day FREE Trial Get Full Access Now!
BIO Expenses CAGR:1Y: 44.40%2Y: 62.63%5Y: 15.40%10Y: 12.23%
BIO - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
BIO Shares Outstanding CAGR:1Y: -4.24%2Y: -2.98%5Y: -1.27%10Y: -0.40%
BIO - Share Buybacks
14-Day FREE Trial Get Full Access Now!
BIO Share Buybacks CAGR:1Y: 358.88%2Y: 169.88%5Y: 81.27%10Y: N/A
BIO - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
BIO Stock-Based Comp CAGR:1Y: -290.57%2Y: N/A5Y: N/A10Y: N/A
BIO - Dividends
14-Day FREE Trial Get Full Access Now!
BIO Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
BIO - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
BIO Revenue CAGR:1Y: 2.79%2Y: -2.31%5Y: 2.99%10Y: 2.05%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BIO - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BIO Actual Revenue CAGR:1Y: 2.79%2Y: -2.31%5Y: 2.99%10Y: 2.05%
BIO - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BIO Actual EPS CAGR:1Y: 541.21%2Y: 149.56%5Y: 36.21%10Y: 50.56%
BIO - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BIO Actual Net Income CAGR:1Y: 514.71%2Y: 144.48%5Y: 35.24%10Y: 49.76%
BIO - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BIO Actual EBITDA CAGR:1Y: 520.56%2Y: 167.91%5Y: 53.93%10Y: 29.24%

Ratios, Profit Margins & Return on Capital:

BIO - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
BIO Net Profit Margin CAGR:1Y: 498.04%2Y: 148.35%5Y: 33.10%10Y: 46.75%
BIO - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
BIO Gross Profit Margin CAGR:1Y: 3.16%2Y: -0.11%5Y: 0.01%10Y: 0.07%
BIO - Price to Earnings
14-Day FREE Trial Get Full Access Now!
BIO - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
BIO - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
BIO - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

BIO Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

BIO Dividend History: Dates, Payments & Yield list

Below is a schedule of all BIO dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for BIO

Based on past 10-year performance, here are BIO growth metrics:

Share price CAGR of +10.46%
Dividend CAGR of +0%
Using BIO CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

BIO
Current Price$327.47
Start Shares30.54
Start Value$10,000
 
After 10 years:
Final Share Count30.54
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$802.03
Total Dividends$0
Final Value$24,492

Estimated Future Value + Dividends - BIO

NOTE: Above numbers are our estimate based on BIO's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Bio-Rad Laboratories, Inc. (BIO) had its IPO on 1980-02-27, and is trader on NYSE stock exchange.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

BIO website: https://www.bio-rad.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial